Read the latest positive news, breakthroughs, and inspiring stories about respiratory health, curated daily by BrightWire.
A respiratory therapy for chronic lung disease reduced emergency care visits while also lowering healthcare emissions by over 25 kg of CO2 per patient annually. The Spanish study shows how better medical treatments can heal both people and the planet.
European regulators just approved the first asthma medication that works for six months with a single dose, offering hope to millions struggling with severe breathing conditions. Irish patients could soon access this groundbreaking treatment that replaces daily medication with just two shots per year.
An Australian nasal spray that blocks respiratory viruses before they make you sick is heading to clinical trials, backed by nearly $10 million from the US military. One spray per week could protect against colds, flu, RSV, and coronaviruses without needing a vaccine for each one.
Mordechai Shedrowitzky spent 23 years watching his breathing worsen from toxic dust exposure on 9/11, but a 2024 surgery finally gave him his life back. The volunteer EMT can now play with his grandchildren and return to work after years of hospitalizations.
A breakthrough treatment for chronic lung disease has shown remarkable results, slashing severe breathing attacks by up to 34% regardless of smoking history. The drug, now awaiting FDA review, could transform life for millions living with COPD.
A breakthrough treatment dramatically reduced dangerous breathing episodes in people with COPD, offering new hope for millions who struggle with one of the world's deadliest lung diseases. The therapy worked across all patient types, filling a critical gap in care.
AstraZeneca's experimental COPD drug tozorakimab succeeded in two late-stage trials, reducing severe flare-ups by up to 34% and offering hope to millions who lack treatment options. The once-monthly injection could reach FDA approval by early 2027.
A groundbreaking new medication could help millions of Americans living with COPD breathe easier, with clinical trials showing it cuts severe symptom flare-ups by up to 34%. For the 16 million Americans battling this deadly lung disease, including those who never smoked, this first-of-its-kind treatment offers real hope.
Scientists discovered why some boys outgrow asthma when they hit their teens. Male hormones help lung nerve cells suppress inflammation and prevent asthma attacks.
Researchers discovered which home factors cause the most respiratory problems after hurricane flooding, giving families and responders a roadmap to protect health before symptoms appear. The breakthrough could prevent illness in millions of flood-affected homes.
Researchers discovered a peptide that works like a molecular switch-off button for the runaway inflammation behind allergic asthma. The nasal spray treatment could help millions dealing with chronic inflammatory diseases.
Researchers discovered that iron released in the lungs triggers the inflammatory chain reaction behind allergic asthma, which affects 17 million Americans. Blocking this iron pathway stopped asthma symptoms in mice, opening the door to new treatments.